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ABSTRACT
Introduction Precision health requires citizens that 
are empowered to orient health decisions towards their 
personal values, aware of the benefits and risks, and 
committed to sharing their personal data to trustful 
institutions. Effective citizen engagement initiatives 
are fundamental for the success of a precision health 
approach.
Objective To provide an overview of citizen engagement 
initiatives in precision health in European Union (EU) 
member states.
Design Scoping review.
Methods The electronic databases PubMed, Web of 
Science, CINAHL and Embase were searched to include 
articles published in English. Furthermore, desk research 
was conducted in English, Dutch, French, Italian and 
Spanish. Articles or reports regarding ongoing initiatives 
of citizen engagement in precision health conducted in EU 
member states and published from January 2015 to July 
2020 were considered eligible. A quality assessment of the 
retrieved entries using Critical Appraisal Skills Programme 
tool was conducted.
Results We identified nine documents, which reported 
eight ongoing citizen engagement initiatives, with 
substantial variability. Government agencies, non- 
governmental organisations and scientific societies were 
the main organisers and funders. Most of the initiatives 
were conducted in the UK. Genomics was the most 
emphasised aspect of precision health in these initiatives. 
Among the identified initiatives, both in- person and digital 
means were reported.
Conclusion Our work provides an overview of current 
citizen engagement initiatives in the EU that can be useful 
for stakeholders interested in designing and developing 
precision health projects enriched by meaningful citizen 
participation.
PROSPERO registration number CRD42020193866.
INTRODUCTION
Precision health is a vision and approach 
to health and healthcare that aims to use 
the ever- growing quantity and quality of 
data about personal genome, lifestyle and 
environment to respond to the need for 
more precise treatments and prevention.1 A 
personalised approach to medicine envisions 
and requires citizens who are: (1) aware of 
the benefits and risks of genomic medicine, 
(2) committed to sharing their personal data 
to trustful institutions, and (3) empowered to 
orient health decisions towards their personal 
values.2–5 The adoption of these attitudes 
and behaviours towards personalised health 
is undermined by the poor level of genetic 
literacy found among the general popula-
tion6–8 that has been considered as a signif-
icant barrier9 for the public acceptance of 
genetics and genomics advancement. More-
over, attitudes of the general public towards 
genomic data sharing differ largely across 
the world, and are substantially influenced 
by socioeconomic factors.10 11 Public involve-
ment in health policymaking and governance 
in this field, however, has not been embraced 
by most healthcare organisations.12 Large 
amount of genomic and phenotypic data is 
required from millions of citizens to foster a 
more precise prevention: citizens have to be 
informed about the potential risks and bene-
fits of their personal data, provide insights 
about their priorities, be engaged to feel 
that they are benefiting the entire society.13 
Citizens must be informed on how their data 
contribute to the understanding of human 
health, and also need to be reassured that their 
Strengths and limitations of this study
 ► This scoping review, to our knowledge, is the first to 
identify and summarise ongoing citizen engagement 
initiatives in precision health in European Union (EU) 
member states.
 ► The strength of this scoping review is its compre-
hensive and extensive search in English of four 
electronic bibliographic databases, and additional 
search in Dutch, French, Italian and Spanish on the 
grey literature.
 ► This scoping review acknowledges the limitation 
of not including all the conducted initiatives in EU 
member states in precision health, since they might 
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contribution will bring no personal harm to them or their 
relatives.13 To respond adequately to citizens’ demands, 
scientists and decision- makers need to gather information 
about public knowledge gaps, perceptions and attitudes.2 
Generally speaking, the aim of citizen engagement is 
to increase the citizens’ active participation in health-
care, shaping and guiding research and policymaking 
by setting up the priorities of health programmes.14 15 
Effective citizen education and engagement initiatives, 
by providing and enhancing citizen participation, can be 
crucial to build trust and support evidence generation 
both for and with citizens.16 A review on public engage-
ment initiatives on genomics and personalised medicine 
conducted in 2013, reported a growing number of public 
engagement exercises, mostly conducted outside the 
European Union (EU).17 A more recent scoping review 
found that only one- third of all initiatives reported public 
involvement in any capacity.18 While these activities are 
deemed essential to maintain public trust and improve 
research outcomes and equity, reporting of such initia-
tives is often scarce.18 Given the growing interest in more 
precise and data- driven approaches to health and health-
care in Europe, it is important to explore and understand 
the current scenario of citizen engagement initiatives in 
precision health in the context of the EU member states.
Citizen engagement is one of the focus of the European 
project ‘European network staff eXchange for integrAting 
precision health in the health Care sysTems’, that aims 
to design and promote innovative citizen engagement 
models.1 Our scoping review has been developed within 
this project, aiming to explore and analyse the publicly 
available documents related to citizen engagement that 
reported initiatives, in order to inform policymakers on 
the current landscape of citizen engagement initiatives in 
precision health in EU member states.
METHODS
We conducted and reported a scoping review in accor-
dance with the Preferred Reporting Items for Systematic 
reviews and Meta- Analyses extension for Scoping Reviews 
checklist (online supplemental file 1).19
The protocol of this scoping review has been registered 
in the International Prospective Register of Systematic 
Reviews (PROSPERO; online supplemental file 2).
Eligibility criteria
The research question and eligibility criteria for inclu-
sion in our work were formulated according to the PICO 
framework:20
P (population): European citizens living in EU member 
states.
I (intervention): initiatives, models or platforms, 
ongoing or concluded in 2020.
C (comparator): not applicable.
O (outcome): citizen engagement, participation, 
involvement or empowerment in precision health.
Based on the PICO framework, publicly available articles 
or reports regarding ongoing citizen engagement initia-
tives and, containing considerations on the preparation, 
development, or implementation of citizen engagement 
models were considered eligible. For the purpose of this 
article, we considered a ‘citizen engagement initiative in 
precision health’ any process, strategy or model initiated 
by public entities (governmental or non- governmental 
agencies, universities or scientific societies) with the aim 
of informing, involving, empowering or fostering citizens' 
participation in approaches to health and healthcare 
that leverage the use of personal data to inform a more 
precise decision- making. Several dimensions have been 
analysed, which aimed at engaging people as: individuals 
in relation to health treatments and issues; as citizens who 
consider the future promises of precision health; and as 
health policymakers or stakeholders to decide future 
precision health priorities. Considering that there is not a 
universal consensus around the definition of personalised 
medicine, or precision health, we included the terms 
‘genomic\personalised\precision’ and ‘health\medicine’ 
as reported by the original documents.
We included articles and reports published in English, 
French, Spanish, Dutch and Italian language. Commen-
taries, editorials, conference abstracts, reviews, clinical 
case reports, clinical case series and book chapters were 
excluded.
Search strategy
Two authors (AMP and IH) performed the search on 
PubMed, Web of Science, CINAHL and Embase elec-
tronic databases, using the following search terms and 
related synonyms: “citizen”, “population”, “community”, 
“public”, “engagement”, “participation”, “involvement”, 
“empowerment”, “precision health”, “precision medi-
cine”, “precision healthcare”, “personalised medicine”, 
“personalized healthcare”, “initiative”, “model”, “plat-
form” and “framework”.
Search strategies for the four scientific electronic data-
bases are provided in online supplemental file 3.
In a second step, two authors (AMP and MS) performed 
desk research independently, exploring the grey liter-
ature through Google, Bing and Yahoo search engines, 
using the same search terms, which were then translated 
to Dutch, French, Italian and Spanish to retrieve docu-
ments written in languages other than English. Addition-
ally, in order to retrieve additional reports, two authors 
(AMP and MS) explored the websites of EU institutional 
agencies, including the EU Commission, European 
Public Health Association and European Alliance for 
Personalised Medicine.
The search for both scientific and grey literature 
included documents, articles and reports published from 
1 January 2015 to 20 July 2020. We limited our search 
to documents published in 2015 or after, considering 
that in 2015, the EU health ministries defined person-
alised medicine, in the Council conclusions on person-
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EU- funded project ‘PerMed’ defined developing aware-
ness and empowerment as one of the five challenges of 
personalised medicine, in its report ‘Shaping Europe’s 
Vision for Personalised Medicine’.21
Study selection and data extraction
After the scientific literature search, the identified articles 
were uploaded to Mendeley software and duplicates were 
removed. The remaining articles were exported to Rayyan 
QCRI software, where two independent authors (AMP 
and IH) performed the first screening based on titles and 
abstracts. The pertinent articles with full texts available were 
reviewed by three authors (AMP, MS and IH) and the articles 
satisfying the eligibility criteria were included in the scoping 
review. Furthermore, their reference lists were manually 
searched for any additional relevant publication.
Regarding the grey literature search, two authors (AMP 
and MS) searched for grey literature independently 
and selected documents of interest by screening them 
by title, headings, summary and abstract. A list with the 
potentially eligible documents was created in Excel and, 
subsequently, full texts of these documents were assessed 
against our inclusion criteria by two researchers (AMP 
and MS) independently. Eventually, a hand search of 
reference lists of included documents was performed.
For each of the included documents, we extracted the 
following data: first author; publication year; country, 
language; project name, coordinator and funder; covered 
topic, citizen engagement method, objective and partici-
pants' characteristics.
Syntheses of results
Articles were categorised according to the type of citizen 
engagement method, using Excel spreadsheets. Aggregate 
data were used to provide a qualitative synthesis of each 
reported citizen engagement method: digital tools, citizen 
forums, open discussions, participation in governing 
committees and audiovisual tools. Two researchers (MS 
and IH) were involved in the data synthesis process 
and discrepancies will be resolved by consulting a third 
researcher (AMP). In order to analyse the level of public 
participation in the identified citizen engagement initia-
tives, we used the International Association of Public 
Participation (IAP2) spectrum of public participation22 
that classifies public participation processes based on 
their goals: from information/consultation (low level of 
impact on the decision- making) to involvement (medium 
level) to collaboration/empowerment (high level).
Quality assessment
We assessed the methodological quality of the included scien-
tific articles using the Critical Appraisal Skills Programme 
(CASP) checklist for qualitative studies.23 This validated tool 
contains 10 questions about the objectives, appropriateness 
of study design and qualitative methods, eligibility and selec-
tion criteria, data collection strategy, researcher–participant 
relationship, ethical aspects, data analysis, statement of find-
ings and value of the findings. Three authors (AMP, MS and 
IH) performed the quality assessment independently and 
any disagreement was resolved through discussion.
Patient and public involvement
Patient and the public were not involved in this study.
RESULTS
The study screening and selection process is reported 
in details in figure 1. The scientific and grey literature 
search led to the identification of a total number of 1411 
records. After removal of duplicates, 1102 records were 
screened by title, headings, summary, abstract or table of 
content, according to our eligibility criteria. Then, the full 
text of 91 records were carefully read. Finally, we included 
in our scoping review nine documents, four of which were 
retrieved through scientific literature search24–27 and five 
were identified through grey literature search.27–31 Arti-
cles retrieved by the scientific literature search were of 
qualitative study designs. The main characteristics of the 
included initiatives are reported in table 1.
The identified documents were published between 
2015 and 2020 and reported eight initiatives. Six initia-
tives (75%) were developed in the UK,24–29 one (12.5%) 
in Spain30 and one (12.5%) in Belgium.31 32 Six initiatives 
(75%) were conducted at the national level,25–28 30 31 one 
initiative had a more local focus29 and the other one was 
carried out at international level.24
Figure 1 Flow chart of the selection and screening process 
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Regarding the main topic, most initiatives (75%, n=6) 
focused on genomics or omics sciences,24 26–29 31 32 while one 
(12.5%) dealt more specifically with issues surrounding 
the access to personal health data for scientific, medical 
and/or policy planning purposes,25 and one (12.5%) 
concerned cancer and the role of precision medicine in 
this field.30 In particular, the focus of genomics involve-
ment activities were expectations, understanding and 
attitudes towards willingness to donate personal data, 
secondary access to data, and ethical, legal, social impli-
cations of genomics in society.
One document addressed the engagement of partic-
ipants of research studies in a data access governance 
committee,25 whereas other seven reported initiatives that 
were directed to the general population.24 27–32 Six initia-
tives were aimed at a wider engagement by including in 
the process also policymakers, researchers and experts, 
and industry.25 26 28–32
Quality assessment
The quality assessment of the four scientific articles 
included in our review, using CASP checklist for qualita-
tive studies, is reported in table 2.
In particular, all fields evaluated by the aforementioned 
checklist were deemed as satisfactory for most included 
studies. The only exception is represented by the item 
investigating if the relationship between the researcher 
and participants has been adequately taken into account, 
in particular in terms of critical examination of the 
researcher’s role, potential bias and influence during the 
formulation of the research questions and data collection, 
which was evaluated not satisfactory for two studies.25 27 
Hence, study findings were evaluated ‘valuable’ for all the 
included articles, for the appropriate contextualisation 
of results in the landscape of current literature and the 
considerations about applications of findings.
Citizen engagement methods and aims
The included initiatives described a variety of citizen engage-
ment methods in various aspects of precision health. Each 
method is discussed separately in the next paragraphs.
Digital tools
Three initiatives used digital tools as means to achieve 
citizen engagement, two used web platforms and apps 
as the sole means to connect with citizens,24 27 while one 
used blended (in- person and online) methods.26 The 
website of Genomics England initiative, providing infor-
mative materials for public consultation, was considered 
of utmost importance to obtain public support needed to 
achieve the final objective of 100,000 Genome Project.26 
Additionally, in order to gain public trust, focus groups, 
meetings, patient panels, public events and discussions 
were suggested as the key elements of public engage-
ment and involvement in precision medicine.26 Samuel 
and colleagues also highlighted the support for public 
engagement among people working in or being associ-
ated with Genomics England and a potential conflicting 
role when who is in charge to engage people is also in 
charge of gaining public support.26 Another tool devel-
oped to make more accessible and understandable to the 
public information regarding genome and methylome, 
is the GenoME app. This free access app enables people 
to explore the genetic code, including information for 
ancestry, eye colour, health, smoking and age. The main 
purpose of this app was to have actual people presenting 
real incidental findings in an innovative and engaging 
way. The GenoME app is reported as a novel mode for the 
public to engage with personal and medical genomics.27
Citizen forums
The citizen forum ‘My DNA, everybody’s concern’ in 
Belgium, concluded that citizens should have control over 
the use of genomic information to protect their privacy, 
and this has to be taken into account by policymakers.31 32 
‘A public dialogue on Genomic Medicine’ was a citizen 
forum, commissioned for Ipsos MORI by Genomics 
England and others, mainly aimed at assessing public 
views and attitudes to genomics, informing the ongoing 
political environment and developing an understanding 
of the language and terms that the public and other stake-
holders use in association with genomic medicine. This 
work detailed citizens’ views, concerns and aspirations 
towards genomic medicine, and also giving suggestions 
on how to operationalise them.28 The two citizen forums 
were the only projects to report independent evaluation 
processes.28 31 32 The Genomics England citizen forum 
evaluation was conducted by a consultancy firm special-
ising in socioeconomic analyses; they concluded that the 
citizen forum was able to meet the predefined objectives, 
satisfy the participants’ expectations and have policy 
impact.33 The Sciensano citizen forum evaluation process 
was led by university researchers and reported a high 
quality level of public deliberation through an inclusive 
and transparent process that enabled participants to influ-
ence the process in the making and arrive at informed, 
considered judgements and recommendations.34
Open discussions
The initiative Dialogos de Salud y Cancer (‘Cancer and 
Health Dialogues’) consisted of a travelling exhibition that 
aimed at increasing participants’ knowledge about cancer 
and precision medicine through virtual reality, questions and 
answers, and interactive films.30 Moreover, the report of the 
Progress Educational Trust open discussion underlines the 
need for more public education regarding the benefits and 
limitations of genomic medicine.29
Participation in governing committees
Instead, the study developed within the Managing Ethico- 
social, Technical and Administrative issues in Data ACcess 
(METADAC) committee, a multiagency multistudy data 
access structure that serves several of the major cohort 
studies in UK, describes the involvement of study partici-
pants in the decision- making process as a way to improve 
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participants, with their involvement growing together 
with and according to their knowledge level.25
Audiovisual tools and surveys
The project ‘Your DNA, your say’, part of the Regula-
tory and Ethics Work Stream of the Global Alliance for 
Genomics and Health, was an online survey used as a 
means for the assessment of public attitudes towards 
donating and sharing own genomic information and 
data, with the support of short videos that were aimed at 
both helping study participants understand and answer 
the questions of the questionnaire and raising awareness 
about genomics and big data. The authors of this project 
reported on the profile of people unwilling to donate 
their genomic information: more likely to be older, of 
lower education background, childless and identifying 
themselves as part of an ethnic minority.24
Extent of public participation in the projects
A variable degree of public deliberation, that ranges 
from simpler open discussions29 30 to structured citizen 
forums28 31 32 is described in most initiatives. The level of 
public participation was:
 ► Low at five initiatives, such as: open discussions29 30 
aimed at informing the population and increasing the 
literacy of citizens; ‘the public dialogue on genomic 
medicine’,28 and the corporate strategy of Genomics 
England26 aimed at consulting the citizens to establish 
current public understanding; and Your DNA, your 
say24 that aimed at both informing and consulting the 
citizens.
 ► Medium at two initiatives: inclusion in the METADAC 
committee25 and the Personal Genome Project UK 
GenoME app27 aiming at involving the citizens in 
improving accessibility to data and data sharing.
 ► High, at two initiatives, which through the investiga-
tion of public opinion and attitudes gathered useful 
information to produce citizen- oriented recommen-
dations to influence policy choices.26 28 31 32
DISCUSSION
In the present work, we provided an overview of ongoing 
citizen engagement activities in precision health in the 
EU member states. We identified eight engagement 
initiatives, ongoing or recently concluded, that varied in 
the way through which citizen engagement occurred and 
was reported. The engagement methods used in the iden-
tified initiatives were open discussions, citizen forums, 
digital tools, such as tablet apps and online platforms, 
survey with audiovisual tools and advisory board involve-
ment. The majority of these initiatives were aimed at gath-
ering citizen perspectives to inform policymaking, or at 
establishing current public understanding on precision 
health, mostly with a focus on genomics.
Prior to 2015, reported citizen engagement initiatives 
worldwide included quantitative10 17 35 36 and qualita-
tive surveys,11 18 public deliberation models,1 7 36 37 focus 
groups,17 36 38–40 science cafés,41 online platforms42 and 
boards participation.17 36 38 40 The increasing number 
of citizen engagement initiatives in recent years in EU 
member states is likely due to a growing interest by 
national and European authorities in precision health, 
and other personalised approaches to health, evidenced 
by the development of national plans by some coun-
tries43 44 and also by the foundation in 2016 of the Inter-
national Consortium for Personalised Medicine.45
The main topic of most of the initiatives included in 
our scoping review was genomics, which together with 
the other omics sciences, set up the basis of personalised 
approaches to health. This was expected since previous 
literature has examined the main topic of public involve-
ment initiatives and found a similar focus on under-
standing and attitudes towards genomics.17 Moreover, 
genomic techniques are commonly associated with the 
terms ‘precision’ and ‘personalised’ and these terms were 
used in the search strategy.
We reported high variability for the included projects in 
citizen engagement methods, aims and degree of public 
participation. This, in part, reflects the general diversity in 
components and aims of citizen engagement.46 We report 
different levels of public participation in the projects ranging 
from low24 29 30 to high.28 31 32 The highest degree of public 
participation was reached through the citizen forum, that 
represents a way to create practical policy output with involve-
ment of citizens, experts, stakeholders and policymakers.32 
This collaborative and deliberative approach offers an alter-
native to a market- based approach or authoritarian approach 
where one actor in the field of genomics might determine 
the entire playbook.47 According to Manafò et al, the degree 
of public deliberation is strictly related to time, knowledge 
and funds needed for public engagement initiatives.15 Six out 
of eight initiatives included in this scoping review had a low- 
to- medium level of public deliberation that may be due to 
a lack of resources invested in citizen engagement activities.
In our review, many of the citizen engagement activities 
were conducted through digital means. There is contrasting 
evidence regarding the use of digital means in public involve-
ment activities: Etchegary and Wilson reported in 2013 only 
one initiative that used digital means to engage with citi-
zens,17 while in the scoping review on public involvement in 
genomics research by Nunn et al, 7 out of 32 initiatives used 
online tools,18 hence this may reflect an evolution towards 
a more conspicuous role of digital means in citizen engage-
ment activities.
We note that outcomes of the citizen engagement initia-
tives are scarcely defined and reported, and only two initia-
tives28 31 32 were independently evaluated in the process.33 34 
This is in line with a review on public participation in health-
care priority setting that found that engagement exercises 
are rarely formally evaluated.48 In our scoping review, public 
consultations were typically made una tantum or at the begin-
ning of a broader precision health project. Most of the iden-
tified initiatives engaged citizens at the consultation level on 
the IAP2 spectrum, by generally asking for input at set points 
in the process and not providing an ongoing opportunity for 
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that engage citizens in all the levels of the IAP2 spectrum. 
This approach will give them the opportunity to provide 
inputs and receive feedback on how these inputs influenced 
all the aspects of decision- making, throughout the entire 
process. Citizen engagement initiatives can be used to eval-
uate the points of view of citizens toward novel technologies 
and projects to ascertain their acceptability, potential ethical 
issues, and challenges in implementation and scalability, 
while raising awareness and stimulating ownership of the 
decision- making processes.15
The quality of citizen engagement initiatives remains 
a concern for the data gathering and interpretation.49 
Particular attention should be given to the facilitators 
and barriers to the involvement of citizens in these 
initiatives, like reimbursement policies or education 
and training opportunities.16 In 2015, Budin- Ljøsne and 
Harris denounced that the expectation of a high degree 
of commitment by the citizens in personalised medicine 
was not matched by an adequate consideration of the 
educational, technological and socioeconomic barriers in 
place.2 Efforts in citizen engagement are meant to ensure 
that these hurdles are addressed and overcome.
Our findings should be interpreted in the light of some 
limitations and strengths. We recognise as a limitation to our 
work that citizen engagement initiatives may not be reported 
publicly, indicating the possibility of publication bias. Consid-
ering that reports of citizen engagement initiatives in the EU 
member states could be available in many national languages 
and published through a broad range of different media, 
we used a comprehensive and multilanguage grey literature 
search strategy and a careful screening of the references. In 
addition, due to the broad search query, we might have not 
identified initiatives focused on using environmental and life-
style data.
To our knowledge, this is the first review concerning 
citizen engagement initiatives in precision health in the 
EU member states. Our study has also other important 
strengths: (1) the comprehensiveness of our search, 
including four bibliographic databases and different 
strategies to search for grey literature; (2) the inclusivity 
of our search string allowed us to include all the relevant 
documents, regardless of the definition used; and (3) the 
good quality of the included documents.
With reference to policy and practical implications, 
considering our findings, it is of utmost importance to 
include the literacy and engagement of citizens as an 
emerging policy priority in the national governmental 
strategies and plans. Policy development process should 
directly include citizens in different steps of the policy 
cycle, that could enable the implementation in a more 
effective and efficient way. Therefore, they should be 
engaged, particularly, in the initial step of identifying 
policy priorities, as well as in the policy planning and 
implementation phases.
Citizens should also participate in research endeavour, 
such as the actual knowledge production, being involved 
in the definition, collection, use and validation of scien-
tific results. There is a need to build citizens’ capabilities, 
for participatory and deliberative practices of policy elab-
oration and service delivery; therefore, their educational 
needs and socioeconomic hurdles should be properly 
addressed. Particular attention should be paid to policy 
challenges and gaps, as well as to facilitators and barriers 
to the involvement of citizens in these initiatives.
CONCLUSION
Our work provided an overview of the citizen engage-
ment initiatives in the EU member states and identified 
an increased interest in citizen engagement in preci-
sion health with an increased use of digital means. This 
work might contribute to inform European stakeholders 
involved in designing and developing precision health 
projects enriched by meaningful citizen participation. In 
fact, a shift towards more precise and personalised health 
and healthcare is considered a priority by the EU and 
requires strong and engaged citizens to ensure it.
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